Oxygen News and Research

RSS

Scripps Research scientists produce chemically complex compound

In 1993 researchers discovered a chemical compound in a sponge off Palau, an island nation in the Pacific Ocean, that has shown anticancer, antibacterial, and antifungal pharmaceutical promise. But that wasn't its greatest allure, at least not for chemists.

13 Jan 2010

First sulfite-free rectal suspension for UC

sfRowasa™ (mesalamine) Rectal Suspension 4g/60mL –Sulfite-Free Formulation, is the first sulfite-free rectal suspension available for Ulcerative colitis (UC). According to a study published in The American Journal of Gastroenterology, products containing sulfites may exacerbate natural sulfide levels in the colon and may increase inflammation in UC patients. With its sulfite-free preparation, sfRowasa™ offers a new treatment option for the treatment of active, mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis.

13 Jan 2010

Pall acquires U.S. biotechnology company

Pall Corporation, a global leader in filtration, separation and purification, today announced its acquisition of MicroReactor Technologies, Inc. (MRT), a privately held U.S. biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.

From Pall Corporation 12 Jan 2010

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

The public, including parents of babies with severe heart defects, are invited to submit questions for inclusion in a tweet chat about surgical approaches for heart defects from noon-2 p.m. Wednesday, Jan. 20 on Twitter.

12 Jan 2010

Finesse Solutions releases TruFluor sensors and TruTorr headspace pressure sensors

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, announced the production release of its single-use sensor product family: TruFluor sensors for dissolved oxygen or pH and process temperature, and TruTorr headspace pressure sensors.

12 Jan 2010

Researchers discover new ways for treatment of cancer

Researchers at the Swedish medical university Karolinska Institutet have discovered a new way of blocking the formation of blood vessels and halting the growth of tumours in mice. A substance that exploits this mechanism could be developed into a new treatment for cancer.

12 Jan 2010

Researchers identify treatment to reduce health problems associated with enzyme defect

An experimental compound repaired a defective alcohol metabolism enzyme that affects an estimated 1 billion people worldwide, according to research supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

10 Jan 2010

Research into "chemical chaperone" may lead to new treatments for heart attacks

Researchers at the Indiana University and Stanford University schools of medicine have determined how a "chemical chaperone" does its job in the body, which could lead to a new class of drugs to help reduce the muscle damage caused by heart attacks.

10 Jan 2010

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Los Alamos National Laboratory (www.lanl.gov) has identified the Top 10 Laboratory science stories of 2009 based on global viewership of online media content and major programmatic milestones.

9 Jan 2010

Oxygen Biotherapeutics' common stock approved for listing on NASDAQ Capital Market

Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for listing on the NASDAQ Capital Market.

9 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

Microlife Medical Home Solutions, Inc. (MiMHS) announces The Biggest Loser medical staff will implement the MedGem indirect calorimeter to assess metabolic changes in program contestants. The MedGem handheld indirect calorimeter is an FDA-cleared, Class II, medical device that assesses metabolic rate by measuring a patient’s resting oxygen consumption.

7 Jan 2010

E-The Environmental Magazine: Environmental toxicity drives up autism rates

As many as one in 90 children are today being diagnosed with autism--and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates--environmental toxicity.

7 Jan 2010

New survival prediction equation may impact clinical trials for treating PAH

Setting out to determine the survival of patients with pulmonary arterial hypertension (PAH), researchers at the University of Chicago Medical Center and their colleagues also discovered that an equation used for more than 20 years to predict survival is outdated.

6 Jan 2010

Animal experiments show old antidepressant may reverse heart failure

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

6 Jan 2010

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at the Translational Genomics Research Institute (TGen) and Johns Hopkins University and published Jan. 6 in the scientific journal PLoS ONE.

5 Jan 2010

Scientists identify the cause of age-related muscle loss

If you're an aging baby boomer hoping for a buffer physique, there's hope. A team of American scientists from Texas and Michigan have made a significant discovery about the cause of age-related muscle atrophy that could lead to new drugs to halt this natural process. This

5 Jan 2010

Study shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism

A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.

4 Jan 2010

Simulated Environment Concepts completes negotiations with Zen & O to manufacture 250 SpaCapsules

Simulated Environment Concepts, Inc., makers of the high pressurized dry water massage and relaxation station SpaCapsule, announced that it has completed negotiations with the French company Zen & O, securing a multi-million dollar deal to manufacture 250 SpaCapsules over the next four years.

4 Jan 2010

Oxygen News and Research

Scripps Research scientists produce chemically complex compound

First sulfite-free rectal suspension for UC

Pall acquires U.S. biotechnology company

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

Finesse Solutions releases TruFluor sensors and TruTorr headspace pressure sensors

Researchers discover new ways for treatment of cancer

Researchers identify treatment to reduce health problems associated with enzyme defect

Research into "chemical chaperone" may lead to new treatments for heart attacks

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Oxygen Biotherapeutics' common stock approved for listing on NASDAQ Capital Market

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

E-The Environmental Magazine: Environmental toxicity drives up autism rates

New survival prediction equation may impact clinical trials for treating PAH

Animal experiments show old antidepressant may reverse heart failure

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Scientists identify the cause of age-related muscle loss

Study shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism

Simulated Environment Concepts completes negotiations with Zen & O to manufacture 250 SpaCapsules

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News